Preparative and Process Chromatography Market worth $12.8 billion by 2026 - Exclusive Report by MarketsandMarkets™
The COVID-19 pandemic has significantly affected the preparative and process chromatography market. With the increasing threat associated with COVID, researchers are highly dependent on analytical laboratory techniques such as chromatography to gain effective and efficient methods for characterizing the virus and analyze potential vaccines and anti-COVID-19 compounds.
As the battle against the deadly SARS-CoV-2 virus continues, researchers rely on analytical laboratory techniques like chromatography to provide effective and efficient methods for characterizing the virus and analyzing potential vaccines and anti-COVID-19 compounds.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151748164
Browse in-depth TOC on "Preparative and Process Chromatography Market"
340 – Tables
48 – Figures
330 – Pages
"Process Chromatography are expected to hold the largest share of the preparative and process chromatography market, by type in 2021."
Based on type, the market has been segmented into process chromatography and preparative chromatography. In 2020, the process chromatography segment accounted for the largest share of the market. This is mainly due to the increasing production of pharmaceutical products and rising investments in the pharma biotech industry. Moreover, with the outbreak of COVID-19, there has been a rise in demand for vaccines and drugs for treatment, hence driving the demand for process chromatography products.
"Biotechnology & pharmaceutical Industries are expected to hold the largest share of the preparative and process chromatography market, by end user in 2021."
Based on end user, the preparative chromatography market has been segmented into biotechnology & pharmaceutical industries; food and nutraceutical industries; and research laboratories. The biotechnology & pharmaceutical industries segment accounted for the largest market share in 2020. This can primarily be attributed to the increasing research activities by pharmaceutical & biotechnological companies and the rising demand for monoclonal antibodies and insulin by these industries.
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian